Effect of combined continuity care guided by Orem&apos;s self-care model and low FODMAP diet on gut microbiota composition and symptoms in patients with irritable bowel syndrome

Celiac DiseaseIrritable Bowel Syndrome (IBS) and Chronic Constipation

Effect of gluten and wheat on symptoms and behaviours in adults with irritable bowel syndrome: a single-centre, randomised, double-blind, sham-controlled crossover trial

Lancet Gastroenterol Hepatol

Seiler CL, Rueda GH, Miranda PM, Nardelli A, Borojevic R, Hann A, Rahmani S, De Souza R, Caminero A, Curella V, Neerukonda M, Vanner S, Schuppan D, Moayyedi P, Collins SM, Verdu EF, Pinto-Sanchez MI, Bercik P

doi: 10.1016/S2468-1253(25)00090-1

Inflammatory Bowel Disease

A study on the utility of inflammatory biomarkers in primary care irritable bowel syndrome: a sub analysis of the DOMINO randomized trial

BMC Gastroenterol

Tack C, Van den Houte K, Besard L, Capiau L, Ceulemans S, Gernay O, Maes S, Peetermans C, Raat W, Stubbe J, Van Boxstael R, Vandeput O, Van Steenbergen S, Gehesquière B, Raes J, Tack J, Carbone F

doi: 10.1186/s12876-025-04494-7

RECOMMENDED

Inflammatory Bowel DiseaseFurther Publications

Smoking affects gut immune system of patients with inflammatory bowel diseases by modulating metabolomic profiles and mucosal microbiota

★ 1 Recommended by Prof. Dr Stephan Vavricka, Faculty Member

Gut

Miyauchi E, Taida T, Uchiyama K, Nakanishi Y, Kato T, Koido S, Sasaki N, Ohkusa T, Sato N, Ohno H

doi: 10.1136/gutjnl-2025-334922

Irritable Bowel Syndrome (IBS) and Chronic Constipation

Efficacy of gut-brain neuromodulators in irritable bowel syndrome: an updated systematic review and meta-analysis

Lancet Gastroenterol Hepatol

Khasawneh M, Mokhtare M, Moayyedi P, Black CJ, Ford AC

doi: 10.1016/S2468-1253(25)00051-2

Inflammatory Bowel Disease

MRI assessment of body composition for prediction of therapeutic response to biologic agents in patients with Crohn's disease

Insights Imaging

Sakai NS, Plumb AA, Ahmed N, Chowdhury K, Kilic Y, Hameed M, Patel A, Bhagwanani A, Helbren E, Hyland R, Bhatnagar G, Sidhu H, Lambie H, Franklin JM, Mohsin M, Thomson E, Boone D, Tolan D, Rahman S, Ding N, Moran GW, Bloom S, Hart A, Menys A, Travis S, Halligan S, Taylor SA, Motility trial investigators

doi: 10.1186/s13244-025-01930-w

Celiac DiseaseIrritable Bowel Syndrome (IBS) and Chronic Constipation

Global prevalence of celiac disease in patients with Rome III and Rome IV irritable bowel syndrome: A systematic review and meta-analysis

Am J Gastroenterol

Shiha MG, Schiepatti A, Manza F, Maimaris S, Aziz I, Sanders DS

doi: 10.14309/ajg.0000000000003586

Hepatology

Effectiveness of a model of care based on Fibrosis-4 and liver stiffness measurement for the screening of patients with type 2 diabetes mellitus at risk of advanced liver disease: results from an Italian prospective multicentre study

Am J Gastroenterol

Caviglia GP, Ferro A, D'Ambrosio R, Perbellini R, Lampertico P, Periti G, Valenti L, Ciccioli C, Pennisi G, Petta S, Brodosi L, Petroni ML, Marchignoli F, Pironi L, Sagripanti A, Argenziano ME, Svegliati-Baroni G, Rosso C, Barutta F, Armandi A, Gruden G, Bugianesi E

doi: 10.14309/ajg.0000000000003493

RECOMMENDED

Inflammatory Bowel Disease

Gaps between European Crohn's and Colitis Organisation quality standards of care and the real world on diagnosis and monitoring inflammatory bowel disease across Europe: results from the E-QUALITY survey

★ 3 Recommended by Prof. Dr Stephan Vavricka, Faculty Member

J Crohns Colitis

Fiorino G, Fidalgo C, Adamina M, Barreiro-de Acosta M, Ali MP, Bortlik M, Burisch J, Dignass A, Drobne D, Faiz O, Ferrante M, Fierens L, Godny L, Gojdicova A, Iacucci M, Jӓghult S, Karmiris K, Kirchgesner J, Restellini S, Rosini F, Shouval D, Yanai H, Zagórowicz E, Walsh A, European Crohn’s Colitis Organisation

doi: 10.1093/ecco-jcc/jjaf105

Inflammatory Bowel Disease

Bowel Urgency in Crohn's Disease: Effects of Mirikizumab in a Randomized Controlled Phase 3 Trial

Clin Gastroenterol Hepatol

Jairath V, D'Haens G, Sands BE, Travis S, Chaparro M, Peyrin-Biroulet L, Chen MH, Dubinsky M, Ferrante M, Schreiber S, McGinnis K, Vadhariya A, Appelmans S, Lin Z, Yu G, Protic M, Moses R, Ghosh S

doi: 10.1016/j.cgh.2025.07.003

Gastroenterology

Effect of combined continuity care guided by Orem's self-care model and low FODMAP diet on gut microbiota composition and symptoms in patients with irritable bowel syndrome

Related content

Effect of gluten and wheat on symptoms and behaviours in adults with irritable bowel syndrome: a single-centre, randomised, double-blind, sham-controlled crossover trial

A study on the utility of inflammatory biomarkers in primary care irritable bowel syndrome: a sub analysis of the DOMINO randomized trial

Smoking affects gut immune system of patients with inflammatory bowel diseases by modulating metabolomic profiles and mucosal microbiota

Efficacy of gut-brain neuromodulators in irritable bowel syndrome: an updated systematic review and meta-analysis

MRI assessment of body composition for prediction of therapeutic response to biologic agents in patients with Crohn's disease

Global prevalence of celiac disease in patients with Rome III and Rome IV irritable bowel syndrome: A systematic review and meta-analysis

Effectiveness of a model of care based on Fibrosis-4 and liver stiffness measurement for the screening of patients with type 2 diabetes mellitus at risk of advanced liver disease: results from an Italian prospective multicentre study

Gaps between European Crohn's and Colitis Organisation quality standards of care and the real world on diagnosis and monitoring inflammatory bowel disease across Europe: results from the E-QUALITY survey

Bowel Urgency in Crohn's Disease: Effects of Mirikizumab in a Randomized Controlled Phase 3 Trial